Adient
ADNT NYSE Automotive Parts & Equipment Financials FY2016βFY2025
Adient's revenue fell 1.0% to $14.5 billion in fiscal 2025. Its net margin was β1.9%, down from 0.1% a year earlier. Free cash flow was $204 million, down 26.4%. It paid out $125 million in dividends and buybacks, 61% of free cash flow. The diluted share count fell 7.9%.
What Adient does
No business description yet.
- Legal name
- Adient plc
- Fiscal year ends
- September 30, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0001670541-25-000152
0001670541
Revenue and margins
Adient had $14.5B of revenue in fiscal 2025, down 1.0% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $204M in fiscal 2025, 1.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Adient returned $125M to shareholders in fiscal 2025, 61% of free cash flow. The diluted share count fell 7.9%.
Value Adient yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$1.4B and divides by 83.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 30.2x Β· peers 20.4x Β· sector 17.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Adient can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.5B | $947M | $1.1B | $945M | $958M |
| Debt incl. finance leases | $3.7B | $2.6B | $2.5B | $2.4B | $2.4B |
| Net debt / EBITDA | 1.1x | 2.7x | 1.9x | 2.2x | 3.4x |
| Debt / equity | 1.6x | 1.2x | 1.1x | 1.1x | 1.4x |
| Interest coverage | 7.3x | 1.3x | 3.2x | 1.7x | 0.5x |
| Current ratio | 1.5x | 1.2x | 1.2x | 1.1x | 1.1x |
| Quick ratio | 1.2x | 0.9x | 0.9x | 0.9x | 0.9x |
| Total assets | $10.8B | $9.2B | $9.4B | $9.4B | $9.0B |
| Total liabilities | $8.1B | $6.8B | $6.9B | $6.9B | $6.9B |
| Shareholders' equity | $2.4B | $2.1B | $2.2B | $2.1B | $1.8B |
| Net debt (β = net cash) | $2.2B | $1.6B | $1.4B | $1.5B | $1.4B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.7M
4 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Peter CarlinDirector | Sold | 7,843 | $19.25 | $0.2M | Form 4 |
| Jun 4, 2026 | David HerbergEVP, Emea | Sold | 699 | $22.58 | $0.0M | Form 4 |
| Jun 4, 2026 | Heather M TiltmannEVP, CLO, CHRO & Secretary | Sold | 22,000 | $22.71 | $0.5M | Form 4 |
| Nov 26, 2025 | Michel Pierre Rose BerthelinEVP, Emea | Sold | 2,500 | $19.71 | $0.0M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 6 / 9 | 5 / 9 | 5 / 9 |
| Accruals ratio | β5.0% | β5.6% | β8.0% |
| Altman Z'' | 0.78 | 0.58 | 0.29 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Adient ADNT | $1.3B | β1.0% | β | 1.4% | 2.0% | 30.2x | 5 | |
| BorgWarner BWA | $11.3B | 1.6% | 3.7% | 8.2% | 4.6% | 27.1x | 7 | Compare β |
| Autoliv ALV | $8.4B | 4.1% | 10.1% | 6.6% | 20.3% | 13.8x | 8 | Compare β |
| Aptiv APTV | $9.1B | 3.5% | 5.8% | 7.5% | 3.7% | 40.3x | 8 | Compare β |
| Lear LEA | $5.9B | β0.2% | 3.3% | 2.3% | 8.9% | 10.9x | 7 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $16.8B | $16.2B | $17.4B | $16.5B | $12.7B | $13.7B | $14.1B | $15.4B | $14.7B | $14.5B |
| Gross profit | $1.6B | $1.4B | $904M | $801M | $592M | $826M | $807M | $1.0B | $928M | $961M |
| Research and development | $460M | $488M | $513M | $454M | $370M | $316M | $322M | $362M | $372M | $387M |
| Interest expense | $5.0M | $129M | $143M | $137M | $203M | $229M | $192M | $132M | $187M | $183M |
| Pretax income | $377M | $1.1B | β$1.1B | $2.0M | β$429M | $1.4B | $54.0M | $295M | $133M | β$88.0M |
| Income tax | $1.8B | $99.0M | $480M | $410M | $57.0M | $249M | $94.0M | $0.0M | $32.0M | $103M |
| Net income | β$1.5B | $877M | β$1.7B | β$491M | β$547M | $1.1B | β$120M | $205M | $18.0M | β$281M |
| Diluted EPS | β$16.50 | $9.34 | β$18.06 | β$5.25 | β$5.83 | $11.58 | β$1.27 | $2.15 | $0.20 | β$3.39 |
| Diluted shares | 0.09B | 0.09B | 0.09B | 0.09B | 0.09B | 0.10B | 0.09B | 0.10B | 0.09B | 0.08B |
| Cash flow | ||||||||||
| Cash from operations | β$1.0B | $746M | $679M | $308M | $246M | $260M | $274M | $667M | $543M | $449M |
| Capital expenditure | $437M | $577M | $536M | $468M | $326M | $260M | $227M | $252M | $266M | $245M |
| Free cash flow | β$1.5B | $169M | $143M | β$160M | β$80.0M | $0.0M | $47.0M | $415M | $277M | $204M |
| Depreciation and amortization | $344M | $358M | $447M | $318M | $332M | $330M | $350M | $340M | $332M | $325M |
| Stock-based compensation | $28.0M | $45.0M | $47.0M | $20.0M | $15.0M | $36.0M | $29.0M | $34.0M | $31.0M | $32.0M |
| Acquisitions | $0.0M | $247M | $0.0M | $0.0M | $0.0M | $211M | $19.0M | $6.0M | $0.0M | $0.0M |
| Share buybacks | $0.0M | $40.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $65.0M | $275M | $125M |
| Dividends paid | $0.0M | $52.0M | $103M | $26.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends and buybacks | $0.0M | $92.0M | $103M | $26.0M | $0.0M | $0.0M | $0.0M | $65.0M | $275M | $125M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $105M | $709M | $687M | $924M | $1.7B | $1.5B | $947M | $1.1B | $945M | $958M |
| Total debt | $3.5B | $3.5B | $3.4B | $3.7B | $4.3B | $3.7B | $2.6B | $2.5B | $2.4B | $2.4B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $1.0M | $1.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $5.7B | $4.5B | $4.3B | $4.1B | $4.5B | $5.1B | $4.2B | $4.3B | $4.1B | $4.1B |
| Current liabilities | $4.3B | $4.3B | $4.2B | $3.8B | $3.8B | $3.5B | $3.5B | $3.7B | $3.7B | $3.7B |
| Inventory | $660M | $735M | $824M | $793M | $685M | $976M | $953M | $841M | $758M | $695M |
| Property and equipment, net | $2.2B | $2.5B | $1.7B | $1.7B | $1.6B | $1.6B | $1.4B | $1.4B | $1.4B | $1.4B |
| Total assets | $13.0B | $13.2B | $10.9B | $10.3B | $10.3B | $10.8B | $9.2B | $9.4B | $9.4B | $9.0B |
| Total liabilities | $8.6B | $8.6B | $8.2B | $8.2B | $8.7B | $8.1B | $6.8B | $6.9B | $6.9B | $6.9B |
| Shareholders' equity | $4.2B | $4.3B | $2.4B | $1.8B | $1.2B | $2.4B | $2.1B | $2.2B | $2.1B | $1.8B |
| Margins | ||||||||||
| Gross margin | 9.6% | 8.6% | 5.2% | 4.9% | 4.7% | 6.0% | 5.7% | 6.7% | 6.3% | 6.6% |
| EBITDA margin | 4.3% | 9.6% | β3.0% | 2.8% | 0.8% | 14.6% | 4.2% | 5.0% | 4.4% | 2.9% |
| Net margin | β9.2% | 5.4% | β9.7% | β3.0% | β4.3% | 8.1% | β0.9% | 1.3% | 0.1% | β1.9% |
| FCF margin | β8.8% | 1.0% | 0.8% | β1.0% | β0.6% | 0.0% | 0.3% | 2.7% | 1.9% | 1.4% |
| Returns | ||||||||||
| Return on capital | β | 14.3% | β12.1% | 1.3% | β3.9% | 30.5% | 2.8% | 10.7% | 6.2% | 2.0% |
| Return on capital employed | β | 13.6% | β12.5% | 2.1% | β3.5% | 24.3% | 3.8% | 7.5% | 5.6% | 1.7% |
| Return on equity | β31.2% | 20.8% | β50.5% | β23.2% | β35.7% | 61.7% | β5.4% | 9.5% | 0.8% | β14.4% |
| Return on assets | β13.2% | 6.7% | β14.0% | β4.6% | β5.3% | 10.5% | β1.2% | 2.2% | 0.2% | β3.1% |
| Growth | ||||||||||
| Revenue growth | β16.2% | β3.4% | 7.6% | β5.2% | β23.3% | 8.0% | 3.2% | 9.0% | β4.6% | β1.0% |
| Net income growth | β436.1% | β | β292.1% | β | β | β | β110.8% | β | β91.2% | β1,661.1% |
| EPS growth | β436.7% | β | β293.4% | β | β | β | β111.0% | β | β90.7% | β1,795.0% |
| FCF growth | β | β | β15.4% | β211.9% | β | β | β | 783.0% | β33.3% | β26.4% |
| Share count change | β0.1% | 0.2% | β0.6% | 0.3% | 0.2% | 2.0% | β0.9% | 0.6% | β5.6% | β7.9% |
| Financial health | ||||||||||
| Net debt / EBITDA | 4.7x | 1.8x | β | 6.2x | 24.7x | 1.1x | 2.7x | 1.9x | 2.2x | 3.4x |
| Debt / equity | 0.8x | 0.8x | 1.4x | 2.0x | 3.6x | 1.6x | 1.2x | 1.1x | 1.1x | 1.4x |
| Interest coverage | 76.4x | 9.2x | β6.8x | 1.0x | β1.1x | 7.3x | 1.3x | 3.2x | 1.7x | 0.5x |
| Current ratio | 1.3x | 1.0x | 1.0x | 1.1x | 1.2x | 1.5x | 1.2x | 1.2x | 1.1x | 1.1x |
| Quick ratio | 1.2x | 0.9x | 0.8x | 0.9x | 1.0x | 1.2x | 0.9x | 0.9x | 0.9x | 0.9x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.6% | 3.6% | 3.1% | 2.8% | 2.6% | 1.9% | 1.6% | 1.6% | 1.8% | 1.7% |
| Stock comp / revenue | 0.2% | 0.3% | 0.3% | 0.1% | 0.1% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% |
| Payouts / FCF | β | 54.4% | 72.0% | β | β | β | 0.0% | 15.7% | 99.3% | 61.3% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 4.0 | 4.0 | 5.0 | 3.0 | 7.0 | 4.0 | 6.0 | 5.0 | 5.0 |
| Altman Z'' | 1.5 | 1.4 | β0.5 | 0.1 | β0.2 | 2.1 | 0.6 | 0.8 | 0.6 | 0.3 |
| Accruals ratio | β4.4% | 1.0% | β19.6% | β7.5% | β7.7% | 8.1% | β4.0% | β5.0% | β5.6% | β8.0% |
Source: SEC EDGAR XBRL filings (CIK 0001670541). Data updated October 19, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.